# Inhaled Nitric Oxide for the Treatment of Neonatal Hypoxic Respiratory Failure With Pulmonary Hypertension

> **NCT07099144** · — · RECRUITING · sponsor: **Lee's Pharmaceutical Limited** · enrollment: 120 (estimated)

## Conditions studied

- Pulmonary Hypertension
- Hypoxic Respiratory Failure

## Interventions

- **DRUG:** Inhaled nitric oxide (NO)

## Key facts

- **NCT ID:** NCT07099144
- **Lead sponsor:** Lee's Pharmaceutical Limited
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-12-12
- **Primary completion:** 2025-12-31
- **Final completion:** 2026-12-30
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2025-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07099144

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07099144, "Inhaled Nitric Oxide for the Treatment of Neonatal Hypoxic Respiratory Failure With Pulmonary Hypertension". Retrieved via AI Analytics 2026-06-29 from https://api.ai-analytics.org/clinical/NCT07099144. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*